AFP and fatty liver disease: To better understand the significance of NS5A in hepatic steatosis, we generated a mouse model by intravenously injecting recombinant lentiviral particles carrying the coding region of the NS5A protein, under the control of a mouse albumin promoter and AFP enhancer, into C57BL/6 J mice via their tail vein.